British Society for Surgery of the Hand Live Podcast
elcome to the Upper Hand Podcast, where Chuck and Chris talk hand surgery. We are two hand surgeons at Washington University in St. Louis, here to talk about all things hand surgery related, from technical to personal. Please subscribe wherever you get your podcasts, and thank you in advance for leaving a review and a rating. That helps us get the word out. You can email us at [email protected]. So let's get to the episode.
Charles Goldfarb 0:30
Oh, hey Chris.
Chris Dy 0:31
Hey Chuck, how are you?
Charles Goldfarb 0:32
I'm great. I'm great. How are you?
Chris Dy 0:35
Good. We're excited. This is an intro to the a very special episode which we were invited to film and record at the British Society for Surgery of the Hand meeting in Edinburgh.
Charles Goldfarb 0:45
Yeah, it was a great meeting, and we'll talk about it more. But first, we want to thank our sponsors. The Upper Hand is sponsored by PracticeLink.com, the most widely used physician job search and career advancement resource.
Chris Dy 1:01
Finding the right job doesn't have to be. Becoming a physician is hard. Finding the right job doesn't have to be. How many times have I read that? Join PracticeLink for free today at www.practicelink.com/theilbrant.
Charles Goldfarb 1:15
Oh, it's all good. It's real, real life. Checkpoint Surgical, our other sponsor, recently launched its newest product, Checkpoint Axicore Flexible Nerve Conduit, engineered for flexibility and designed for the toughest anatomies. Its unique corrugated wall structure flexes with movement while maintaining an open, unobstructed lumen, helping protect the regenerating nerve without restricting natural tissue motion, take us home
Chris Dy 1:44
to learn more. Visit checkpointsurgical.com. Hope you guys enjoy the episode. We'll recap more about the meeting. But without further ado, welcome to the Upper Hand
Speaker 1 1:56
Live. The last program for today is the Upper Hand podcast. I am sure many of you have heard the Upper Hand podcast, and many of you regularly hear about it. Hear it, and I was trying to get some statistics on the number of come up, come up, the number of statistics of the downloads. But I think I was I was told this is not an easy thing. And again, how many? 600,000. And I was I was I was thinking why your podcast is so popular, and I think one of the reason is because you always talk about things that are pertinent. You make us think. You you talk about things honestly. I think very importantly, you make us feel many times we are not alone, that we are not the only one struggling. So that's a very very precious thing that you've given to a lot of hand surgeons. So thank you for being here, and today we have two very special guests that we would like you to include in your podcast. So can we invite Jane McNeil Dias to come on stage? And the floor is yours. Thank you very much. Yeah,
just turn on your microphones first and check. They're all on. There you go. Okay. Should I get started? Let's go.
Chris Dy 3:57
Welcome to the Upper Hand Live.
Charles Goldfarb 4:06
So we're thrilled you're here. We might not make you think too much as the previous speaker did, but hopefully we'll entertain a little bit. And you know, Chris and I've been doing this for six years, more than six years, going on seven years, and clearly, as we said, there's been some nerve struck. Chris likes to talk about nerve, so I'm going to mention nerve. That was awful. That was bad. But anyways, we are going to do something a little different today, and we have two wonderful guests, and we're going to hopefully engage each of you. And we love audience participation.
Chris Dy 4:40
Yes. So if you have questions, please have them ready for us. We'll bring it to you guys in a moment, and we'll pick on some friends that I know in the audience. I see Warren here. We know we we're going to talk to you first. But you know, thanks for having us here. It's really nice to be here. I arrived this morning. I'm a little jet lagged, but I did get a lot of sleep on the plane. Chuck's been here. A little bit longer. She's had a chance to acclimate.
Charles Goldfarb 5:02
Yes, we. My wife and I toured the Highlands for three days, and I knew Scotland was a beautiful country, and I knew Edinburgh was. I did learn how to pronounce it. If you heard our podcast where Chris and I struggled to pronounce your beautiful city, you can laugh at us. But the Highlands were beautiful, and we're thrilled to be here. And thank you.
Chris Dy 5:21
You've got quite a number of presentations you'll be giving while you're here. Is that correct?
Charles Goldfarb 5:25
Yes. So it's not all fun and games. Yes, I'm privileged to give a pioneer lecture tomorrow, discussing evidence in congenital hand surgery and a few other things as well. So it'll be it's going to be a great great week.
Chris Dy 5:38
I think the sessions I'm doing on Friday. One is the Plexus session, which I'm obviously very excited about. But I like the new format for the afternoon session on Friday. It's called "Can I Ask a Simple Question." So, for those of you that are organizing that, thank you. It's it's it's going to touch on a lot of things. The topic I have to talk about is mistakes, complications, and difficult times. So, not a fun thing to reflect on, but certainly one that I've spent some time putting it together, and I'm excited to to share my experiences. So hopefully, you guys will tune in for that too.
Charles Goldfarb 6:05
Yeah, and a good sports session tomorrow afternoon with a couple of tips from a lot of different people from BSSH and the AAHS and myself. So it'll that'll be fun as well.
Chris Dy 6:17
Exciting. So we have two wonderful guests here. If you would like to introduce yourselves, I'm sure everybody here knows who you are and about your work, but it'd be nice if you could tell for the people listening at home.
Speaker 2 6:26
Sure, it's really nice to be part of this podcast. My name is Jane McKechnie. I'm a consultant hand surgeon in Fife, just north of Edinburgh. Edinburgh is my home city, and I'm editor in chief of the Journal of Hand surgery European volume.
Chris Dy 6:42
Wonderful, thank you, Jane. Hi,
Speaker 3 6:44
I'm Joe Dias. I'm an orthopedic surgeon from Leicester. Leicester is the center of gravity of the whole of the UK. If you take the map of Leicester and you put up of the UK and you hold it up with a pin, it'll be in Leicester. And I would suggest you go home and try it out. I
Chris Dy 7:09
will. It'd be a fun experiment.
Charles Goldfarb 7:10
Well, if you take a pin and put it in St. Louis, Missouri, we might be the epicenter of hand surgery. I mean, there may have to be some people who disagree for the United States, so we're we're very similar in that regard,
Chris Dy 7:23
basically.
Charles Goldfarb 7:24
Yeah, yeah.
Chris Dy 7:25
Well, looking over the work that all of you have accomplished, we has asked us to do some reflection. So the first question that he asked, and maybe I'll act as host since I'm the most junior by far here by far by far, is what operation have you stopped doing and why? Maybe start with with Jane if you don't mind.
Speaker 2 7:43
That seems fitting since I'm the most junior by far.
Speaker 3 7:48
Beauty, beauty before
Speaker 2 7:51
beauty before age. This is a really difficult question for me because I couldn't think of anything, and I became a consultant in 1999, just on the back of the downward trend with rheumatoid surgery, the introduction of DMARDs, and because I knew I needed an answer, I took my logbook, which has 20,000 patients in it, going back 20 years. I anonymised it and I said, "Dear ChatGPT, what have I stopped doing that I used to do?" And ChatGPT said, "You have been remarkably consistent."
Chris Dy 8:31
That's amazing.
Speaker 2 8:34
So I do a little bit more of everything because the population of Fife, where I work, has increased over the years, a little bit less industrial injuries because the UK brought in the Health and Safety Acts of 2008-2015, which has reduced serious injury in this lower socio-economic demographic that I work with. But other than that, I have been remarkably consistent.
Chris Dy 9:05
And Joe
Speaker 3 9:05
Jane, I have not been consistent. I've just, if you look back over my career, there are lots of things that I don't do now that I did before. But the principles are there, and what I'm trying to help use to help patients are the same, and a classic example is distal radius fractures. You know, I started off when started off being taught how to use casts, and so I used casts mainly non-operative methods, and then I went through this phase of doing different treatments as they became the current fashion, and it was principally that not that people were trying to promote external fixators or mobile external fixators or docile pie plates or or palmer plates or fragment specific plates. But there was no consistency throughout that time, and my journey with distal radius fractures is each time there was a new way of treating it, I just took over doing it, and then as quickly stopped doing doing it as it passed. At the minute, the thing that challenges me and the theoretical basis of
treatments are ligament stabilizations in the wrist. You know, you are doing it, but you don't know what the impact of what you are doing is having. So I don't know whether that is the next operation that I might stop. So, yep,
Chris Dy 10:42
a lot of food for thought there, Chuck. You want to go next?
Charles Goldfarb 10:45
Yeah. So first, I was thinking of the first comment about ChatGPT, and I did something similar recently. I took all my cases, blinded them, put them in a secure Claude. I'm a Claude guy, not a ChatGPT guy, and I looked for trends in what I'd done over my too many years, and I pride myself now on being a congenital hand surgeon and a sports surgeon. Unusual combination, and it was a little distressing to me to see that the three most common surgeries were bread and butter hand surgeries: carpal tunnel, trigger, and cubital tunnel, by far, which is not unexpected, but despite the change in practice patterns, those those just dominated. Chris and I were talking earlier about, and we'd love to hear if anyone in the audience would want to share procedures we no longer do from a congenital hand standpoint. I don't do the Huber opposition transfer anymore. I do an FDS opposition transfer. I know most of you in the room could care less because most don't do either. But I think that's been a
very positive change. And a little controversial is I have a relatively young population, but I used to perform a fair number of scaphoid excision and forebone fusions. I almost never do that operation anymore. Proximal carpetomies have been so much more effective, with so fewer complications for me that I've changed my practice in that regard.
Chris Dy 12:10
Now, with regards to the first for the Huber, why do you like the FDS opposition more than the Huber?
Charles Goldfarb 12:16
So my mentor, Paul Manske, taught me a great deal about congenital hand surgery, and that was his go-to operation. So for many years, that's what I did. I'm sure everyone in the audience has a similar story. But the FDS opposition transfer is more powerful, more reliable, and it doesn't doesn't fibrose over time. And for all of those reasons, it's it's in my mind a better operation.
Chris Dy 12:40
And then for the four corners or your lack thereof, what do you do when there's wear at the base of the capitate? How do you handle that? Just do it anyway.
Charles Goldfarb 12:48
Yeah, I haven't do. I by a show of hands, who in the audience has done a capitate resurfacing with a metal implant? Not many.
Chris Dy 12:58
Two hands. I see two.
Charles Goldfarb 12:58
If if you like it, two hands. Ah, So not not yeah I I use capsular interposition and I would say I've been somewhat happy with that so my indications for a forebone fusion today is is more significant wear on the head of the capitate or a patient less than 30 years of age otherwise I'll do a proximal carpectomy
Chris Dy 13:20
so the two procedures that I've stopped doing, one is SL reconstruction, because I don't think any of us have it figured out. At least I don't have it. You know, in my hands, it doesn't work the way that others have made it work. Does anybody here still do actively do SL reconstruction, not repair, but reconstruction? And if you're happy with it, put two hands up. Okay, a lot of so-sos. Okay, so I've stopped doing that. I'm much more nihilistic with the SL than I used to be, but I've only you know been in practice about a decade. So, and then the the second procedure I've stopped doing that I started doing early on was ultrasound guided carpal tunnel release. Does anybody do that here? Okay, we got some hands on the back. Looks like about six or seven people. Okay, out of the 1000s that are here, I participated in the the industry-funded randomized trial in the U.S. for that newer device, which is quite expensive. And while my procedure results, I think, were really solid and similar
to the patients who had a mini open, the complication rates were slightly higher at the other institutions, so for me, I've stopped doing it. It was more stressful, took longer, was more expensive, and didn't have a meaningful difference in outcomes for me. Anyone in the audience have a procedure they no longer do that they are dying to share with all of us? Your chance to be on the pod. okay. Well, that one's not controversial. I didn't say that. So, silicone implants was one really good answer. Yeah, I remember silicone implants. Yeah, in the carpus, the radial head. Yes.
Charles Goldfarb 15:00
Too much synovitis. Absolutely. Anyone else? Ah, of course. Here we go. Here we go. And what do you do instead of trapeziectomies? And how long have you been doing joint replacements? And your results are absolutely. Yeah, I think most in the audience appreciate the United States is a decade, perhaps behind the European experience, and there's a lot of excitement around the joint replacements. By a show of hands, who would perform a trapeziectomy today for a 55-year-old with CMC arthritis? By a show of hands, stage Eaton stage three. Painful failed injections. You know the usual. All right, so we got 10%.
Chris Dy 16:24
Yeah, like we counted differently, but okay.
Charles Goldfarb 16:26
And joint replacement.
Speaker 4 16:31
Wow,
Charles Goldfarb 16:32
wow is right.
Chris Dy 16:33
Anybody still doing thumb CMC arthrodesis? Just me. Okay. So decent number there. That was one when we recorded in Boston. That was one point that was brought up that I brought up and that somebody else felt they had a good experience with too. But one thing I love about the the UK experience is that you know we're learning a lot from you know the pioneering work that that your group is doing. And I think that just in general, the UK has always led the way in terms of these very large and important randomized trials. Joe has been involved in led many of them. So, do you guys have any perspective that you'd like to share on thumb CMC or SL or anything like that?
Speaker 3 17:11
I think with the thumb CMC, we have we are in in the phase of a new treatment, and it will find its place and its limits, and I don't think we are still at that point that you are with hips or knees, where you are having to do increasing numbers of revisions, and then we find that colleagues like Sumeet Talwalka will have to become the expert revisionists. So there is a question mark about implants that we don't know what lies ahead. We are hoping that our five-year, 10-year, 15-year results reflects our current experience and our enthusiasm, but that would be something for us to explore, decide, and to know whether revisions are at least reasonable to preserve function. So, and I don't know what colleagues feel about that.
Charles Goldfarb 18:15
I think that certainly feels like what needs to happen for us, Jonathan.
Speaker 4 18:21
I was struggling. to answer the question, but I've suddenly remembered. So the first proper paper I published was abduction extension osteotomy first CMC joint arthritis, and I reviewed the patients myself, and I stand by the results that I published, but then I started doing it as a consultant, and some worked, some didn't, and I don't. I haven't done it for probably 15 years, and so the next question is, why have I not formally retracted it? And I think the answer is, I don't really have enough.
Charles Goldfarb 19:06
You just did.
Speaker 4 19:07
Well,
Charles Goldfarb 19:17
does anyone in the audience do an abduction-extension osteotomy for early thumb CMC arthritis. Which case?
Chris Dy 19:33
All right. So the next question that we had asked us to cover is: What hopes do you have for the next generation of hand surgeons for some of these same issues that we're struggling with, so we could start with maybe with Thumb CMC. Do you think what's the hope for the next generation? Maybe go into other things as well.
Speaker 2 19:50
I think Thumb CMC is a is a great example because it illustrates surgical innovation. It illustrates peer enthusiasm. And it illustrates an operation that we haven't quite come to terms with what the indications are for something that is usually a benign process associated with aging. Where do you set that bar, and you know how do you stop or stop surgeons changing behavior on the back of peer enthusiasm. Maybe Joe has something to say about this.
Speaker 3 20:31
Thanks a lot, Jane, for dropping me in it. I think I'm not that negative. I mean, but I, having spent 40 years in clinical practice, I would love to be starting again because I see so many opportunities to improve what we are doing. You know, simple things like access to care, access to us. You know, rather than having the old-fashioned way, particularly here in the UK, where you've got to do a face-to-face interaction with the patient, and there are other ways of accessing. So you improve access, you improve decision making. Big data is coming in, and we need to learn how to use it, and the main reason to use it is to monitor, predict, and catch the failures before they actually fail. And I think that is on the horizon. And I think this generation will will be addressing that. There's another good challenge for all of us, which is to use our knowledge of genomics and the genome to predict the people, like the arthropaths and all that, predict and then protect function for longer. You
know, rather than start needing a replacement joint at 45 or 55 by doing interventions early, because we know who is going to get it, we might preserve function for longer. So I think those are just three examples of where I think the next 1520 years will will take us.
Charles Goldfarb 22:15
Those are those are great. You know, Chris and I discussed this very question, and I know Wee is going to touch on this in his presidential address, or at least I think he is. The interconnectedness that we all feel, hopefully more and more, in the congenital hand world, where that's manifesting through congenital registries, and right now where they're parallel in many places across the world, but they're not truly interconnected, and so how do we cross the barrier of you know IRBs and human protection to really gather our data together? How do we leverage AI to help with that process? It is a very exciting time, and yeah, I I look forward to what's next. And Chris, being the youngest person on stage is going to tell us what's next.
Chris Dy 23:03
You know, I think that what in my world what we struggle with the most in nerve and plexus is understanding and consistently treating nerve-related pain. You'll hear. I know there are some sessions here on on that exact topic. I think Kyle Eberlin is going to be speaking about that. But I still think that as good as some of those treatments are, we're still not great. We don't have consistent results with treating neuropathic pain, and whether that's surgically, pharmacologically, psychologically, it's going to be a holistic approach that requires a surgeon to have a team surrounding them to to best approach it. And that's what I think I struggle with the most in clinic is, and obviously the the more complex plexus patients are challenging just in terms of function. But the pain part is a is a thread that that is consistent throughout that that population.
Charles Goldfarb 23:52
Our time is winding down. Any comments, questions, burning issues? Warren, Warren is is the vice president of the American Society for Surgery of the Hand, so will be president in a few years. So we we listen to him not at
Speaker 5 24:07
all. Thank you very much, Warren Hammert from Durham, North Carolina. I had a question based in part on what you said, Joe, and then Jane as an editor. So we make changes. You know, we we come up with good ideas, we publish on a technique, and then we make changes. And so I may read something that Joe says. This is a great way to do for a distal radius fracture because it was published by Jane or Wee, and you've made three changes since then. But I'm a young surgeon trying to figure out how to do this. How do we educate people so when you realize something has changed, but we have something published now that we read and we say this is a great article, this is way to do it. How do we prevent people from being impacted when you've realized there's a difference, but it's not published yet.
Speaker 3 24:45
I think that's a really, really great question, and the big gap for the science of surgery is that we don't follow what happens in physics. And in physics, you've got theoretical physics, which has got to be consistent with your knowledge of biology, cell biology, and particularly in nerves, for instance. You need to have all that knowledge, and then you need to have something that you can answer why something is likely to work when somebody offers a treatment and answer all the questions: what happens at the cell level, what happens at the biology of bone healing, what happens in the biology of a ligament repair, you know, and all those things and all those assumptions that we make that the treatments that we offer may not hold up just to that branch of theoretical surgery, where it has got to be consistent. So we need to have that branch of theory, and then you have the second branch of experiments. So you've got experimental physics and theoretical physics, and we need the same,
and it needs to be consistent, you know. So you don't have somebody throwing a plate into the into the treatment options without explaining why it should work and what the harms might be, you know. So, and then we get to the phase of collecting data to prove what our assumptions were, or where the uncertainties were. You know, I've mentioned this about the CMC joint replacement, where we, what do we not know? You know, so we need to be thinking at that step, and then we can approach joined-up delivery of care, where groups of experts are selected to do the first stage. You know, to give the rest of us the assurance that what we are going to offer are individual patients. You know, in front of us in clinic, that we've got the confidence of offering that particular treatment.
Charles Goldfarb 27:06
Jane, this
Speaker 2 27:09
is a very difficult question for me. In my role as editor-in-chief, it is my responsibility to make sure a measured, scientific, scientifically based literature is published. We do have various types of articles. One of them is a roundtable article, in which we collect experts, ask the questions about the elephant in the room, and let the experts discuss. And hopefully, that gives younger surgeons some idea of the thinking behind some of these things that haven't come through as strong recommendations from a scientific perspective. But if anybody has the answer to this, then come and speak to me afterwards, because it is a heavy responsibility that we carry as editors.
Charles Goldfarb 28:01
I think that's right, and you know, various meetings have tried to have this on the agenda, the Journal of Attraction, or whatever you want to call it. But it's just tricky. It's tricky to make happen. I think that's why we all come to meetings, because then you have the conversations that guide you know what you read in the literature. Maybe one final comment.
Speaker 6 28:21
No, I was going to actually talk about the general retraction from the ASSH. I distinctly remember the inertial procedure, and everyone was going to throw spitballs at him for that procedure. And it was nice just to see him say it doesn't work.
Chris Dy 28:38
Well, I think that this has been a fun session. I hope that you will come up and thank Chuck for all of his efforts with the podcast. He does all the editing and everything. But thank you to our guests for joining us. It's been a pleasure, Joe and Jane, to have you on. And hopefully, you guys have enjoyed the session. And please feel free to let us know what else you want to hear about on the podcast. And certainly say hello during the meeting. And it's nice to have you guys here. Thank you. Thank you.
Speaker 1 29:06
Wasn't that great? We hope you will, Chuck and Chris. We hope you will continue your podcast. We hope you won't give up. I know it's difficult. Every Sunday morning, 6 a.m. I believe the podcast will be available soon for download. Join me in showing our appreciation to Chuck and Chris for the live upper hand podcast here at BSSH. And join me in thanking our two very brave guests, Jane and Joe. Thank you.
Charles Goldfarb 29:45
Hey, Chris, that was fun. Let's do it again real soon.
Chris Dy 29:48
Sounds good. Well, be sure to email us with topic suggestions and feedback. You can reach us at [email protected].
Charles Goldfarb 29:55
And remember, please subscribe wherever you get your podcast.
Chris Dy 29:59
And be sure to. A review that helps us get the word out.
Charles Goldfarb 30:03
Special thanks to Peter Martin for the amazing music.
Chris Dy 30:06
And remember, keep the upper hand. Come back next time.
Transcribed by https://otter.ai
You May Also Like

John Michael Godier's Event Horizon
John Michael Godier

Head Shepherd
Mark Ferguson

Vida Eterna. Respuestas desde la Ciencia | Dr. Manuel Sans Segarra
Dr. Manuel Sans Segarra

Outrage + Optimism: The Climate Podcast
Persephonica and Global Optimism

Глобальный доступ на рынок медицинских изделий
Pure Global

Trent Loos Podcast
Trent Loos

The Grave Talks | Haunted, Paranormal & Supernatural
Ghost Stores, Haunted, Paranormal & Supernatural Stories

The Best of Coast to Coast AM
iHeartPodcasts and Coast to Coast AM

Eye On The Sky
Vermont Public

Bedtime Astronomy
Synthetic Universe
Community discussion